Trial Profile
A Clinical Evaluation of Dual Antiplatelet Therapy Duration Following Treatment With the Medtronic Endeavor Zotarolimus-eluting Coronary Stent.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms SEASIDE
- 19 Oct 2020 Status changed from active, no longer recruiting to completed.
- 21 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 01 Sep 2009 New trial record